Hepalink
Hepalink was established in 1998 and restructured in 2007 to be a limited liability company.
Launch date
Employees
Market cap
CAD2.3b
Enterprise valuation
CAD2.7b (Public information from Sep 2024)
Share price
CNY9.19 002399.SZ
Shenzhen Guangdong (HQ)
Financials
Estimates*
| CNY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 5.3b | 6.4b | 7.2b | 5.4b | 6.0b | 6.4b | 6.8b |
| % growth | 15 % | 19 % | 12 % | (24 %) | 10 % | 6 % | 7 % |
| EBITDA | 2.0b | 1.1b | 1.4b | 653m | 1.2b | 1.3b | 1.4b |
| % EBITDA margin | 37 % | 17 % | 20 % | 12 % | 19 % | 20 % | 21 % |
| Profit | 1.0b | 241m | 727m | (783m) | 975m | 748m | 850m |
| % profit margin | 19 % | 4 % | 10 % | (14 %) | 16 % | 12 % | 13 % |
| EV / revenue | 5.0x | 4.0x | 3.0x | 3.2x | 2.4x | 2.6x | 1.8x |
| EV / EBITDA | 13.5x | 23.6x | 14.8x | 26.3x | 12.6x | 12.9x | 8.6x |
| R&D budget | 160m | 221m | 252m | 182m | - | - | - |
| R&D % of revenue | 3 % | 3 % | 4 % | 3 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | IPO | |
| Total Funding | - | ||
Related Content
Recent News about Hepalink
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Hepalink
Edit
ACQUISITION by Sanofi Jan 2021
ACQUISITION by Hepalink Jan 2014
exited
